As of March 31, 2026 and 2025, there were 186,141,070 and 177,515,227 shares of common stock issued, respectively, and 183,955,495 and 175,965,052 shares of common stock outstanding, respectively. Outstanding shares as of March 31, 2026 and 2025, have been adjusted to reflect 2,185,575 and 1,550,175 treasury shares, respectively.

Basic net loss per share is computed by dividing the net earnings attributable to common shareholders by the weighted-average number of common shares outstanding during the period.

Diluted loss per share is computed by dividing net income attributable to common shareholders by the weighted-average number of common shares outstanding, increased to include the number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued. Conversion or exercise of the potential common shares is not reflected in diluted earnings per share unless the effect is dilutive. The dilutive effect, if any, of outstanding common share equivalents is reflected in diluted earnings per share by application of the treasury stock method, and if-converted method, as applicable.

The following tables reconcile actual basic and diluted earnings per share for the three months ended March 31, 2026 and 2025:


	Three Months Ended

	March 31, 2026			March 31, 2025
(in thousands, except per share data)
Numerator:
Net loss	$	(1,300	)	$	(3,231	)
Denominator:
Weighted-average common shares outstanding:
Basic		181,032,929			175,974,990
Diluted		181,032,929			175,974,990
Net loss per common share
Basic	$	(0.01	)	$	(0.02	)
Diluted	$	(0.01	)	$	(0.02	)

The anti-dilutive securities excluded from the weighted-average shares used to calculate the diluted net loss per common share for the three months ended March 31, 2026 and 2025 were as follows:


	March 31, 2026		March 31, 2025

Shares unvested and subject to exercise of stock options		10,660,733		10,576,983
Shares subject to exercise of warrants		175,000		5,456,200